Antimicrobial treatment of multiple sclerosis...Infection. 2006 Dec;34(6):342-4
| Publicado en: | Infection Vol. 35; no. 5; pp. 383 - 386 |
|---|---|
| Autores principales: | , |
| Formato: | commentary letter Journal Article |
| Publicado: |
Springer Nature
Oct2007
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105834763&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105834763 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 03008126 NXO jtl: Infection issn: 03008126 maglogo: N pubinfo: dt: Oct2007 vid: 35 iid: 5 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 105834763 2009687793 10.1007/s15010-007-7036-5 NLM17882356 105834763 ppf: 383 ppct: 3 formats: fmt: @attributes: type: P tig: atl: Antimicrobial treatment of multiple sclerosis...Infection. 2006 Dec;34(6):342-4 aug: au: Stratton CW Wheldon DB affil: The Vanderbilt Clinic 4524-TVC, Vanderbilt University Medical Center, Nashville, TN, USA. sug: subj: Antibiotics Therapeutic Use Erythromycin Therapeutic Use Gram-Negative Bacteria Drug Effects Gram-Negative Bacterial Infections Drug Therapy Multiple Sclerosis Complications pubtype: Academic Journal doctype: commentary letter Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|